An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members

Lisa Belter, Suzanne F. Cook, Thomas Owen Crawford, Jill Jarecki, Cynthia C. Jones, John T. Kissel, Mary Schroth, Kenneth Hobby

Research output: Contribution to journalArticle

Abstract

Background: The Cure SMA database is one of the largest patient reported databases for people affected with SMA. Objective: The purpose of this study was to examine a subset of affected SMA persons with types I, II, and III from a patient reported database. Methods: Individuals with SMA were selected from the database using a date of first contact to Cure SMA between 2010 and 2016. Data analyzed included age at diagnosis, number of weeks from SMA diagnosis to contacting Cure SMA, and geographic distribution of individuals. Results: A total of 1,966 individuals with SMA were included in the analysis. Of these individuals, 51.9% had type I, 32.3% had type II, and 15.8% had type III. The average age of diagnosis for type I patients was 5.2 months, 22.1 months for type II, and 97.8 months for type III. From published incidence, about 59.0% of affected individuals in the US are registered in the Cure SMA database. Conclusions: The Cure SMA database is a unique and robust source of patient reported data that informs on the burden of illness and supports the development of new therapeutic modalities.

Original languageEnglish (US)
Pages (from-to)167-176
Number of pages10
JournalJournal of Neuromuscular Diseases
Volume5
Issue number2
DOIs
StatePublished - Jan 1 2018

Fingerprint

Demography
Databases
Cost of Illness
Incidence
Therapeutics

Keywords

  • birth prevalence
  • nusinersen
  • patient registries
  • patient reported data
  • Spinal muscular atrophy
  • survival

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

An overview of the Cure SMA membership database : Highlights of key demographic and clinical characteristics of SMA members. / Belter, Lisa; Cook, Suzanne F.; Crawford, Thomas Owen; Jarecki, Jill; Jones, Cynthia C.; Kissel, John T.; Schroth, Mary; Hobby, Kenneth.

In: Journal of Neuromuscular Diseases, Vol. 5, No. 2, 01.01.2018, p. 167-176.

Research output: Contribution to journalArticle

Belter, Lisa ; Cook, Suzanne F. ; Crawford, Thomas Owen ; Jarecki, Jill ; Jones, Cynthia C. ; Kissel, John T. ; Schroth, Mary ; Hobby, Kenneth. / An overview of the Cure SMA membership database : Highlights of key demographic and clinical characteristics of SMA members. In: Journal of Neuromuscular Diseases. 2018 ; Vol. 5, No. 2. pp. 167-176.
@article{0980bcd404d547a395afec5b0a3291b1,
title = "An overview of the Cure SMA membership database: Highlights of key demographic and clinical characteristics of SMA members",
abstract = "Background: The Cure SMA database is one of the largest patient reported databases for people affected with SMA. Objective: The purpose of this study was to examine a subset of affected SMA persons with types I, II, and III from a patient reported database. Methods: Individuals with SMA were selected from the database using a date of first contact to Cure SMA between 2010 and 2016. Data analyzed included age at diagnosis, number of weeks from SMA diagnosis to contacting Cure SMA, and geographic distribution of individuals. Results: A total of 1,966 individuals with SMA were included in the analysis. Of these individuals, 51.9{\%} had type I, 32.3{\%} had type II, and 15.8{\%} had type III. The average age of diagnosis for type I patients was 5.2 months, 22.1 months for type II, and 97.8 months for type III. From published incidence, about 59.0{\%} of affected individuals in the US are registered in the Cure SMA database. Conclusions: The Cure SMA database is a unique and robust source of patient reported data that informs on the burden of illness and supports the development of new therapeutic modalities.",
keywords = "birth prevalence, nusinersen, patient registries, patient reported data, Spinal muscular atrophy, survival",
author = "Lisa Belter and Cook, {Suzanne F.} and Crawford, {Thomas Owen} and Jill Jarecki and Jones, {Cynthia C.} and Kissel, {John T.} and Mary Schroth and Kenneth Hobby",
year = "2018",
month = "1",
day = "1",
doi = "10.3233/JND-170292",
language = "English (US)",
volume = "5",
pages = "167--176",
journal = "Journal of Neuromuscular Diseases",
issn = "2214-3599",
publisher = "IOS Press",
number = "2",

}

TY - JOUR

T1 - An overview of the Cure SMA membership database

T2 - Highlights of key demographic and clinical characteristics of SMA members

AU - Belter, Lisa

AU - Cook, Suzanne F.

AU - Crawford, Thomas Owen

AU - Jarecki, Jill

AU - Jones, Cynthia C.

AU - Kissel, John T.

AU - Schroth, Mary

AU - Hobby, Kenneth

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: The Cure SMA database is one of the largest patient reported databases for people affected with SMA. Objective: The purpose of this study was to examine a subset of affected SMA persons with types I, II, and III from a patient reported database. Methods: Individuals with SMA were selected from the database using a date of first contact to Cure SMA between 2010 and 2016. Data analyzed included age at diagnosis, number of weeks from SMA diagnosis to contacting Cure SMA, and geographic distribution of individuals. Results: A total of 1,966 individuals with SMA were included in the analysis. Of these individuals, 51.9% had type I, 32.3% had type II, and 15.8% had type III. The average age of diagnosis for type I patients was 5.2 months, 22.1 months for type II, and 97.8 months for type III. From published incidence, about 59.0% of affected individuals in the US are registered in the Cure SMA database. Conclusions: The Cure SMA database is a unique and robust source of patient reported data that informs on the burden of illness and supports the development of new therapeutic modalities.

AB - Background: The Cure SMA database is one of the largest patient reported databases for people affected with SMA. Objective: The purpose of this study was to examine a subset of affected SMA persons with types I, II, and III from a patient reported database. Methods: Individuals with SMA were selected from the database using a date of first contact to Cure SMA between 2010 and 2016. Data analyzed included age at diagnosis, number of weeks from SMA diagnosis to contacting Cure SMA, and geographic distribution of individuals. Results: A total of 1,966 individuals with SMA were included in the analysis. Of these individuals, 51.9% had type I, 32.3% had type II, and 15.8% had type III. The average age of diagnosis for type I patients was 5.2 months, 22.1 months for type II, and 97.8 months for type III. From published incidence, about 59.0% of affected individuals in the US are registered in the Cure SMA database. Conclusions: The Cure SMA database is a unique and robust source of patient reported data that informs on the burden of illness and supports the development of new therapeutic modalities.

KW - birth prevalence

KW - nusinersen

KW - patient registries

KW - patient reported data

KW - Spinal muscular atrophy

KW - survival

UR - http://www.scopus.com/inward/record.url?scp=85049511546&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049511546&partnerID=8YFLogxK

U2 - 10.3233/JND-170292

DO - 10.3233/JND-170292

M3 - Article

C2 - 29614694

AN - SCOPUS:85049511546

VL - 5

SP - 167

EP - 176

JO - Journal of Neuromuscular Diseases

JF - Journal of Neuromuscular Diseases

SN - 2214-3599

IS - 2

ER -